BTK inhibitor Clinical Trials
2 recruitingDrug
Phase 31
Showing 1–2 of 2 trials
Recruiting
Phase 3
Global Trial in APG2575 for Patients With CLL/SLL
CLL/SLL
Ascentage Pharma Group Inc.400 enrolled2 locationsNCT06104566
Recruiting
Current Status of BTKi Treatment for CLL/SLL in China
CLL/SLL
The First Affiliated Hospital with Nanjing Medical University1,000 enrolled1 locationNCT06508684